Australia's Osteopore rises on regulatory nod for entry to Malaysia
** Shares of Osteopore OSX.AX rise 14.3% to A$0.008, their highest level since March 30 ** Regenerative medicine co receives regulatory nod allowing its entry into Malaysia’s orthopaedic bone reconstruction market ** Stock on track for best day since May 6 if current gains hold ** About 7.5 mln shares change hands, 2.7x the 30-day average of 2.7 mln ** Stock up 23.1% YTD (Reporting by Jasmeen Ara Shaikh in Bengaluru) ((Jasmeenaraislam.Shaikh@thomsonreuters.com;))
Recent news on Osteopore
See all newsBrief: Osteopore Secures Market Access In Thailand For Full Range Of Orthopaedic Products
Brief: Osteopore Strikes Orthopaedic Deal For 5 Middle East Countries
Brief: Osteopore Achieves Market Access To Saudi Arabia For Craniofacial Products
Brief: Osteopore Launches Clinical Study For Paranasal Augmentation In Patients With Unilateral Cleft Lip
Australia's Osteopore advances on regulatory win in China's Hainan